机译:Refractory and relapsed hairy-cell leukemia (HCL): casting light on promising experimental drugs in clinical trials
Medical University Lodz,Med Univ Lodz;
Dept Expt Hematol,Med Univ Lodz;
BRAF; ibrutinib; moxetumomab pasudotox; dabrafenib; hairy cell leukemia; novel drugs; trametinib; variant; vemurafenib; TERM-FOLLOW-UP; HEALTH-ORGANIZATION CLASSIFICATION; DABRAFENIB PLUS TRAMETINIB; PHASE-II; ALLOGENEIC TRANSPLANTATION; COMPLETE REMISSION; BRAF INHIBITION; RITUXIMAB; CLADRIBINE; VARIANT;